Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Blood Advances|December 10, 2019
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Sanjeet Dadwal, Jianying Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2020
Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaAmandeep Salhotra, Dongyun Yang, Sally Mokhtari, et al.
American Journal of Hematology|July 7, 2020
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemiaIbrahim Aldoss, Jianying Zhang, Matthew Mei, et al.
British Journal of Haematology|September 1, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemiaHoda Pourhassan, Jose Tinajero, Huiyan Ma, et al.
Blood Advances|January 10, 2019
MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimenHaris Ali, Ibrahim Aldoss, Dongyun Yang, et al.
Bone Marrow Transplantation|June 10, 2021
Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantationStephanie Mac, Dat Ngo, Dongyun Yang, et al.
Blood Advances|July 15, 2022
Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamideMonzr M Al Malki, Joycelynne Palmer, Ni-Chun Tsai, et al.
Bone Marrow Transplantation|November 8, 2019
Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosisRohan Gupta, Faizi Jamal, Dongyun Yang, et al.
Transplantation and Cellular Therapy|March 30, 2021
Allogeneic Hematopoietic Cell Transplantation for Relapsed and Refractory Philadelphia Negative B Cell ALL in the Era of Novel Salvage TherapiesIbrahim Aldoss, Dongyun Yang, Monzr M Al Malki, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Pageof 7